Cargando…
Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
BACKGROUND: Kidney cancer is one of the most common solid tumors. The advancement of human kidney cancer research and treatment has been hindered by a lack of research models that faithfully recapitulate the diversity of the disease. METHODS: We established an effective three‐dimensional culture sys...
Autores principales: | Li, Zhichao, Xu, Haibo, Yu, Lei, Wang, Jia, Meng, Qian, Mei, Hongbing, Cai, Zhiming, Chen, Wei, Huang, Weiren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270001/ https://www.ncbi.nlm.nih.gov/pubmed/35802820 http://dx.doi.org/10.1002/ctm2.970 |
Ejemplares similares
-
Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2021) -
Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2020) -
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
por: Liu, Lisa, et al.
Publicado: (2021) -
Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro
por: Yu, Lei, et al.
Publicado: (2021) -
Protocol for generation of lung adenocarcinoma organoids from clinical samples
por: Li, Zhichao, et al.
Publicado: (2020)